Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Other Operating Expenses (2016 - 2026)

Avanos Medical's Other Operating Expenses history spans 13 years, with the latest figure at $1.4 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 75.0% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $400000.0, a 89.74% decrease, with the full-year FY2025 number at $400000.0, down 89.74% from a year prior.
  • Other Operating Expenses hit $1.4 million in Q4 2025 for Avanos Medical, up from -$2.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for AVNS hit a ceiling of $11.4 million in Q4 2021 and a floor of -$22.0 million in Q1 2021.
  • Historically, Other Operating Expenses has averaged -$1.7 million across 5 years, with a median of -$550000.0 in 2022.
  • Biggest five-year swings in Other Operating Expenses: crashed 2100.0% in 2021 and later skyrocketed 900.0% in 2025.
  • Tracing AVNS's Other Operating Expenses over 5 years: stood at $11.4 million in 2021, then plummeted by 103.51% to -$400000.0 in 2022, then plummeted by 525.0% to -$2.5 million in 2023, then skyrocketed by 324.0% to $5.6 million in 2024, then crashed by 75.0% to $1.4 million in 2025.
  • Business Quant data shows Other Operating Expenses for AVNS at $1.4 million in Q4 2025, -$2.3 million in Q3 2025, and -$300000.0 in Q2 2025.